Suman Kanungo - Concepedia

Author

Suman Kanungo

National Institute of Cholera and Enteric Diseases ORCID

Also Known As

Kelvin Kering, Ravindra Mohan Pandey, S Kanungo, S. KANUNGO, S. Kanungo, SUMAN KANUNGO, Sneha Kanungo, Suman Kanungo, Suman Kanungo (92300), Swagatika Kanungo

156

Publications

8.6K

Citations

H-Index

Concepts

All Affiliations

National Institute of Cholera and Enteric Diseases International Vaccine Institute Indian Council of Medical Research International Centre for Diarrhoeal Disease Research Johns Hopkins University

About

Suman Kanungo is an author at National Institute of Cholera and Enteric Diseases specializing in medicine, public health, and epidemiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	16	19	4.8K
2	Public Health	13	14	3.9K
3	Engineering	1	1	30
4	Health Sciences	1	1	14
5	Allergy	1	1	78

Suman Kanungo

Publications

Citations

H-Index

Page 1

	Year	Citations
Burden and aetiology of diarrhoeal disease in infants and young children in developing countries (the Global Enteric Multicenter Study, GEMS): a prospective, case-control study Karen L. Kotloff, James P. Nataro, William C. Blackwelder, The Lancet Diarrhoeal DiseasePediatric EpidemiologyGlobal HealthInfant NutritionInternational Health	2013	3.5K
Efficacy, safety, and lot-to-lot immunogenicity of an inactivated SARS-CoV-2 vaccine (BBV152): interim results of a randomised, double-blind, controlled, phase 3 trial Raches Ella, Siddarth Reddy, William C. Blackwelder, The Lancet VaccinationVaccine SafetyVaccine DevelopmentImmunologyInterim Results	2021	358
The Burden of Cryptosporidium Diarrheal Disease among Children < 24 Months of Age in Moderate/High Mortality Regions of Sub-Saharan Africa and South Asia, Utilizing Data from the Global Enteric Multicenter Study (GEMS) Samba O. Sow, Khitam Muhsen, Dilruba Nasrin, PLoS neglected tropical diseases	2016	258
The incidence, aetiology, and adverse clinical consequences of less severe diarrhoeal episodes among infants and children residing in low-income and middle-income countries: a 12-month case-control study as a follow-on to the Global Enteric Multicenter Study (GEMS) Karen L. Kotloff, Dilruba Nasrin, William C. Blackwelder, The Lancet Global Health	2019	252
Efficacy and safety of a modified killed-whole-cell oral cholera vaccine in India: an interim analysis of a cluster-randomised, double-blind, placebo-controlled trial Dipika Sur, Anna Lena Lopez, Suman Kanungo, The Lancet VaccinationVaccine SafetyInterim AnalysisPlacebo-controlled TrialVaccine Efficacy	2009	248
A Cluster-Randomized Effectiveness Trial of Vi Typhoid Vaccine in India Dipika Sur, R. Leon Ochiai, Sujit Bhattacharya, New England Journal of Medicine	2009	240
5 year efficacy of a bivalent killed whole-cell oral cholera vaccine in Kolkata, India: a cluster-randomised, double-blind, placebo-controlled trial Sujit Bhattacharya, Dipika Sur, Mohammad Ali, The Lancet Infectious Diseases VaccinationVaccine SafetyVaccinologyYear EfficacyPlacebo-controlled Trial	2013	235
Diarrhoeal disease and subsequent risk of death in infants and children residing in low-income and middle-income countries: analysis of the GEMS case-control study and 12-month GEMS-1A follow-on study Myron M. Levine, Dilruba Nasrin, Sozinho Acácio, The Lancet Global Health	2019	201
Efficacy of a Low-Cost, Inactivated Whole-Cell Oral Cholera Vaccine: Results from 3 Years of Follow-Up of a Randomized, Controlled Trial Dipika Sur, Suman Kanungo, Binod Sah, PLoS neglected tropical diseases	2011	163
Burden of dengue infection in India, 2017: a cross-sectional population based serosurvey Manoj Murhekar, P Kamaraj, Muthusamy Santhosh Kumar, The Lancet Global Health	2019	143

Page 1